Overview
Ling-hui Ma practices practicing medicine in Beijing, China.
Ma is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Spasticity, Alternating Hemiplegia of Childhood, Hemiplegia, and Stroke.
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ling-hui Ma
Is Ling-hui Ma a top-rated expert for Spasticity?
MediFind is an objective health platform that identifies experts based on real-world data. Ling-hui Ma is classified as an Advanced expert for Spasticity, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ling-hui Ma participate in research or clinical trials?
Yes. Ling-hui Ma has published 13 articles and abstracts on conditions like Spasticity. You can view a list of Ling-hui Ma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Alternating Hemiplegia of Childhood
- HemiplegiaMa isAdvanced. Learn about Hemiplegia.
- SpasticityMa isAdvanced. Learn about Spasticity.
- Experienced
- HypertensionMa isExperienced. Learn about Hypertension.
- StrokeMa isExperienced. Learn about Stroke.